Clinical situations may arise in which a full agonist may be required for patients who currently are being treated with Buprenorphine, such as in the treatment of acute pain. Although this medication interaction has not been studied systematically, the pharmacological characteristics of Buprenorphine suggest that it may be difficult to obtain adequate analgesia with full agonists in patients stabilized on maintenance Buprenorphine.
Data nonspecific to Buprenorphine suggests that, in patients maintained chronically on methadone, the acute administration of full mu agonists for analgesia can be effective. If the necessity should arise for the use of a full mu agonist for pain relief in a patient maintained on Buprenorphine, the Buprenorphine should be discontinued until the pain can be controlled without the use of opioid pain medications. It must be recognized that treatment with full mu agonists for pain relief will produce increased opioid tolerance and a higher degree of physical dependence.